C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT
C4 Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -26.02M | -26.32M | -34.57M | -24.67M | -17.72M | -28.36M | -34.75M | -27.04M | -35.92M | -34.78M | -37.19M | -31.96M | -27.41M | -31.62M | -15.66M | -24.68M | -22.58M |
Depreciation & Amortization | 615K | 456K | 480K | -2.73M | 448K | 2.03M | 1.69M | 447K | 458K | 545K | 521K | 415K | 435K | 305K | 323K | 330K | 388K |
Stock-Based Compensation | 4.99M | 5.51M | 8.23M | 8.83M | 6.38M | 6.21M | 6.36M | 8.2M | 6.42M | 6.25M | 6.92M | 6.01M | 8.15M | 8.94M | 6.35M | 6.09M | 5.23M |
Other Working Capital | 8.25M | -8.25M | 360K | -641K | -5.85M | 4.97M | 14.53M | -10.57M | 7.84M | -7.03M | 401K | -2.74M | -6.32M | -9.04M | -15.06M | -3.65M | -2.57M |
Other Non-Cash Items | -5.46M | 892K | 503K | 3.66M | 45K | 10.53M | 20.16M | 1.65M | 1.75M | 1.08M | 1.28M | 1.72M | 2.3M | 2.02M | 614K | 513K | 505K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -20.87M | -472K | -1.08M | n/a | n/a | n/a | n/a | n/a | 847K | 558K | 372K |
Change in Working Capital | 13.82M | -13.82M | 7.42M | -9.22M | 5.87M | 3.36M | 3.4M | -13.5M | 9.38M | -6.22M | -660K | -4.21M | -5.67M | -6.24M | -18.15M | -1.16M | -1.92M |
Operating Cash Flow | -12.06M | -33.28M | -17.93M | -24.13M | -4.97M | -18.12M | -24.01M | -30.71M | -19M | -33.13M | -29.13M | -28.02M | -22.2M | -26.6M | -25.67M | -18.36M | -18M |
Capital Expenditures | -185K | n/a | 4K | 13K | -197K | n/a | -157K | -600K | -362K | -589K | -1.49M | -3.31M | -529K | -172K | -109K | n/a | -747K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -32.1M | -58.33M | -15.51M | -54.12M | -10.77M | -23.22M | -33.76M | n/a | n/a | n/a | n/a |
Purchase of Investments | -21.68M | -25.64M | -40.78M | -68.56M | -67.22M | -107.75M | -37.88M | -31.94M | -48.64M | -11.44M | -56.29M | -55.11M | -31.91M | -76.22M | -145.42M | -154.7M | -61.32M |
Sales Maturities Of Investments | 60.79M | 54.77M | 54.45M | 68.71M | 55.72M | 54.35M | 69.98M | 90.27M | 64.15M | 65.56M | 67.06M | 78.33M | 65.67M | 72.39M | 86.11M | 54.08M | 94.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -11.51M | -53.4M | 32.1M | 58.33M | 15.51M | 54.12M | 10.77M | 23.22M | 33.76M | -3.83M | -59.3M | -100.63M | 33.18M |
Investing Cash Flow | 38.92M | 29.13M | 13.67M | 162K | -11.71M | -53.4M | 31.95M | 57.73M | 15.15M | 53.53M | 9.28M | 19.91M | 33.23M | -4M | -59.41M | -100.63M | 32.43M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11M | -750K | -750K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -155K | n/a | -85K | n/a | -109K | n/a | -16K | n/a | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 109K | 1K | 297K | 135K | 603K | -1K | 263K | 4K | 104K | 47K | 361K | 259K | 480K | 466K | 1.05M | 170.5M |
Financial Cash Flow | n/a | -46K | 112K | 10.51M | 135K | 34.58M | 57.67M | -10.75M | -746K | -684K | 47K | 361K | 259K | 480K | 466K | 584K | 170.5M |
Net Cash Flow | 26.86M | -4.21M | -4.15M | -10.02M | -16.55M | -36.93M | 65.62M | 16.27M | -4.59M | 19.72M | -19.8M | -7.75M | 11.29M | -30.12M | -84.62M | -118.4M | 184.93M |
Free Cash Flow | -12.24M | -33.28M | -17.93M | -24.12M | -5.17M | -18.12M | -24.17M | -31.31M | -19.36M | -33.71M | -30.62M | -31.32M | -22.72M | -26.77M | -25.78M | -18.36M | -18.75M |